课题基金 / 基金详情

Role of Parkin in Familial and Idiopathic Parkinson's Disease

Role of Parkin in Familial and Idiopathic Parkinson's Disease
Parkin 在家族性和特发性帕金森病中的作用
批准号:
10170978
负责人:
Matthew J Lavoie
金额:
$4.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2021-05-31

项目摘要

项目成果

Matthew J Lavoie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non- motor disturbances. While the etiology of the disease is unknown, genetic mutations responsible for familial forms of PD likely provide critical molecular insights into the underlying mechanisms of idiopathic disease. Loss-of-function mutations in the ubiquitin E3 ligase parkin are the most common cause of autosomal recessive PD. Parkin is now widely recognized as a pro-survival protein that possesses broad ranging effects on mitochondrial biology, and beyond. A more complete comprehension of these functions will will lead to a firmer understanding of the neurodegenerative process in PD, as well as the identification of new pathways that may be targeted for disease modification. The long-term goal of our work is to uncover the molecular machinery responsible for parkin's protective effects in neurons. We propose that both the cytosolic and mitochondrial-localized pools of parkin play important roles in the maintenance of healthy neurons. This application will explore the role of cytosolic parkin in its neuro-protective function in human neurons. Using engineered isogenic and patient based WT and parkin null pluripotent stem cells differentiated to human neuronal fates, we will uncover the conditions that activate the cytoplasmic pool of parkin. We will identify the upstream proteins that control parkin activation and its protection against cell death in human neurons. Then, we will explore the role of BH3 domains in the recognition of an expanding class of putative substrates of cytoplasmic parkin E3 ligase activity. The pathways found to regulate neuronal parkin function may shed light on innovative targets for therapeutic intervention to up-regulate parkin activity and induce neuro-protection in neurologic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease
  • 批准号:
    9791022
  • 项目类别:
  • 资助金额:
    $45.02万
  • 财政年份:
    2018
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
  • 批准号:
    10241552
  • 项目类别:
  • 资助金额:
    $35.12万
  • 财政年份:
    2018
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
  • 批准号:
    10459599
  • 项目类别:
  • 资助金额:
    $35.12万
  • 财政年份:
    2018
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
The Activation of LRRK2 by Alpha-Synuclein
  • 批准号:
    8925936
  • 项目类别:
  • 资助金额:
    $26.0万
  • 财政年份:
    2014
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
国内基金
海外基金
丙泊酚经PINK1/Parkin通路介导线粒体自噬减轻老年患者髋关节置换术后睡眠剥夺相关心肌损伤的机制研究
ATAD3A调控PINK1/PARKIN通路对射血分数保留型心衰中巨噬细胞线粒体自噬和铁代谢稳态的研究
  • 批准号:
    2026JJ82225
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘爱英
  • 依托单位:
SMYD2通过上调PYCR1表达调控PINK1/Parkin线粒体自噬通路促进膀胱癌进展的机制研究
加味独活寄生合剂通过调控Parkin/PINK1通路介导的线粒体自噬抑制NLRP3炎症小体活化治疗KOA的机制研究